🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Novel Post-Surgical Incision Management to Prevent Ostomy Complications

RecruitingNAAges 18 Years - anyAllHealthPartners Institute
NCT06524401 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to evaluate the safety and effectiveness of the Limpet, as compared to standard of care ostomy pouches, in reducing complications for ostomy and fistula patients. Secondary objectives include evaluating dressing leak rates and causes of complications (e.g., edema, tissue oxygen saturation, and poor stoma eversion). The main questions it aims to answer are: Primary Hypothesis 1: Peristomal Skin Complications will decrease Primary Hypothesis 2: Dressing Leak Rates will decrease Participants will: * Receive either the Limpet device or standard of care adhesive ostomy pouch dressing * Return every 7 days for study visits for 30 days to receive device replacement, wound imaging, blood tests, and quality of life surveys.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Participant is greater than 18 years of age, inclusive * Participant is undergoing ileostomy surgery or, * has an enterocutaneous fistula with output over 500cc in 24 hours * Participants stoma will have a maximum diameter of 1.5 inches based on measurements from the Investigator or Sponsor. * Area around the stoma must have no injury through the dermis (i.e., intact skin) * Participant is willing and able to comply with all protocol-specified requirements * Participant is capable of reading and understanding English and will provide written informed consent to participate. Exclusion Criteria: * Unable/unwilling to attend the follow-up appointments * Participant has a life expectancy \< 30 days. * Participant has a stature too small for use of the Limpet in the opinion of the Investigator or Sponsor. * Participant has an enteroatmospheric fistula (enteric fistula to an open wound) * Participant is scheduling/planning concurrent chemotherapy or other radiation treatment during the study follow-up period * Participant has a history of sensitivity or allergy to hydrocolloids or other materials in the Limpet device. * Participant is pregnant or planning to become pregnant (verbal report). * Participant is unable or unwilling to provide informed consent. * Participant is currently participating in an investigational drug or another device study that clinically interferes with the current study endpoints. * Participant has any other disease or medical condition that, in the opinion of the Investigator or Sponsor, could endanger the participant, interfere with the evaluation of the study device's efficacy or safety, or compromise the participant's ability to comply with/complete the study.
💊

What it tests

  • Limpet
  • Control
📍

Where

1 site
Regions Hospital
Saint Paul, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy